BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 5761075)

  • 1. The standardization of the prothrombin time for the control of anticoagulant therapy.
    Biggs R
    Thromb Diath Haemorrh Suppl; 1968; 35():87-92. PubMed ID: 5761075
    [No Abstract]   [Full Text] [Related]  

  • 2. Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
    Denson KW
    Thromb Diath Haemorrh Suppl; 1968; 35():197-208. PubMed ID: 5761492
    [No Abstract]   [Full Text] [Related]  

  • 3. Standardisation of the one-stage prothrombin time test for the control of anticoagulant therapy: the availability and use of thromboplastin reference preparations.
    Nord Med; 1971 Oct; 86(40):1154-5. PubMed ID: 5167204
    [No Abstract]   [Full Text] [Related]  

  • 4. Standardization of the one-stage prothrombin time test for the control of anticoagulant therapy: availability and use of thromboplastin reference preparations.
    Biggs R; Bangham DR
    Br Med J; 1971 Aug; 3(5772):470-1. PubMed ID: 5105905
    [No Abstract]   [Full Text] [Related]  

  • 5. Third report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
    Biggs R; Denson KW
    Thromb Diath Haemorrh Suppl; 1967; 26():445-50. PubMed ID: 6064876
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulant activity of Heraclenin.
    Mishra KC; Sharma RC; Sharma YN; Arora RB
    Indian J Physiol Pharmacol; 1969 Jul; 13(3):153-5. PubMed ID: 5362630
    [No Abstract]   [Full Text] [Related]  

  • 7. Proposed specification for a reference thromboplastin preparation for the control of anticoagulant therapy using coumarin type drugs.
    Denson KW
    Thromb Diath Haemorrh Suppl; 1967; 26():437-40. PubMed ID: 6064874
    [No Abstract]   [Full Text] [Related]  

  • 8. Standardization of the prothrombin time: clinical results with a recombinant tissue factor reagent.
    Kolde HJ
    Haematologica; 1995; 80(2 Suppl):7-13. PubMed ID: 7628775
    [No Abstract]   [Full Text] [Related]  

  • 9. Considerations on an international standard for the one-stage prothrombin time in the control of anticoagulant therapy.
    Loeliger EA; Hemker HC
    Thromb Diath Haemorrh Suppl; 1968; 35():101-5. PubMed ID: 4953165
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on 4-hydroxy-I-thiacoumarins: VI--anticoagulant activity and chemical structure in 4-hydroxy-I-thiacoumarins and related compounds.
    Jamkhandi PS; Rajagopal S; Sirsi M
    Indian J Exp Biol; 1968 Oct; 6(4):224-6. PubMed ID: 5720680
    [No Abstract]   [Full Text] [Related]  

  • 11. Critical appraisal, clinical usefulness, and implementation of the thromboplastin concept of prothrombin-time standardization.
    Loeliger EA; van den Besselaar AM; Bertina RM
    Scand J Haematol Suppl; 1980; 37():34-48. PubMed ID: 7017900
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacodynamics of the oral anticoagulant drugs.
    O'Reilly RA
    Prog Hemost Thromb; 1974; 2(0):175-213. PubMed ID: 4137288
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulant therapy standards: results of two national surveys.
    Poller L
    Thromb Diath Haemorrh Suppl; 1968; 35():115-2. PubMed ID: 5761059
    [No Abstract]   [Full Text] [Related]  

  • 14. Standardization of laboratory tests for controlling anticoagulent therapy.
    Zucker S; Cathey MH; Sox PJ; Hall EC
    Am J Clin Pathol; 1970 Mar; 53(3):348-54. PubMed ID: 5416772
    [No Abstract]   [Full Text] [Related]  

  • 15. [Standardized prothrombin time test for control of anticoagulant therapy].
    Nilsson IM
    Lakartidningen; 1971 Jun; 68(30):3373-4. PubMed ID: 4106374
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study of several thromboplastins used to measure the one-stage prothrombin time.
    Littell AS; Ratnoff OD
    Thromb Diath Haemorrh Suppl; 1968; 35():135-48. PubMed ID: 5761061
    [No Abstract]   [Full Text] [Related]  

  • 17. International Normalized Ratio in patients not on vitamin K antagonists.
    Keeling D
    J Thromb Haemost; 2007 Jan; 5(1):188-9. PubMed ID: 17067366
    [No Abstract]   [Full Text] [Related]  

  • 18. Standardization of the one-stage prothrombin time test for the control of anticoagulant therapy: the availability and use of thromboplastin reference preparations.
    Biggs R; Bangham DR
    Am J Clin Pathol; 1972 Jan; 57(1):117-8. PubMed ID: 5008887
    [No Abstract]   [Full Text] [Related]  

  • 19. International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Thromb Haemost; 1985 Feb; 53(1):155-6. PubMed ID: 3992515
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of the anticoagulant properties of 2 derivatives of 4-hydroxycoumarin].
    Thonnart N; Bourgain R; Reuse JJ
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):408-11. PubMed ID: 5031151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.